This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 23, 2014



















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.


 


AREA & ASSOCIATION NEWS

Greetings,
The University of Arizona
We are fourth year students at the University of Arizona, College of Pharmacy, and we are conducting a research project about your perspectives on your working conditions. We were hoping that you would have time to help us by filling out a brief survey expected to take about 5 minutes to complete.

Your answers are anonymous, and we do not collect any personal information. You can exit the survey at any time if you do not feel comfortable completing it. By completing the survey, you are agreeing to allow us to use your responses in our data analysis.

Click this link or copy it into your web browser to be taken to the online survey:
https://uarizona.co1.qualtrics.com/SE/?SID=SV_6zjQ7J4S5cA6Gfr

For more information about this research project, contact Dr. Richard Herrier at herrier@pharmacy.arizona.edu or 520-626-5240.

We thank you for your participation.

Matthew Noble, Stephanie Lee and Kristin Peterson
Pharm.D Candidates Class of 2015
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Pharmacy Owners: Help to tell the community pharmacy story and you could win $500
NCPA
NCPA has put together its first census to document who you are and what you do. This is your chance to be a part of the bigger story communicated to legislators, regulators, the media and patients. Data from the pharmacy profiles will help NCPA bring new opportunities to community pharmacies.

It is critical that as many community pharmacies as possible complete the census. You can take the census on your mobile phone, tablet or desktop computer in just 8-9 minutes.

Plus, if you complete the survey by the Aug. 4 deadline, you'll be entered into a drawing for a chance to win one of two $500 VISA gift cards! The drawing is limited to one entry per pharmacy/NCPDP number and the survey must be completed in its entirety. Take the census today and help us support community pharmacy.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PHARMACY UPDATES


Hobby Lobby: Progestins and the politics of prevention
By Jason Poquette
I would rather talk about progestins than politics almost any day of the week — they are far more predictable and cause less constipation and nausea. But the recent decision by the Supreme Court concerning Hobby Lobby and whether they have the right to not cover certain specific types of contraception has gotten so much attention from the media that silence seems almost sinful. Progestins and politics have come together. As a pharmacist and U.S. citizen, I suppose it is incumbent upon me to say something.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FedEx accused of conspiracy to distribute prescription drugs for online pharmacies
NBC News
Federal Express was indicted July 17 on federal charges alleging that it distributed prescription drugs and other controlled substances to people that the company knew had no prescriptions on behalf of illegal Internet pharmacies. An 11-count indictment handed down by a grand jury in San Francisco names FedEx Corp. and subsidiaries FedEx Express, Inc. and FedEx Corporate Services, Inc., charges that the firm conspired with two separate but related Internet pharmacy groups identified in the 27-page document as the Chhabra-Smoley Organization and Superior Drugs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword PRESCRIPTION.



IN THE NEWS


Scapegoating the pharmaceutical industry will not solve the healthcare crisis and might even make it worse
Forbes
Pick up any news source and it quickly becomes evident that "big pharma" is the low hanging fruit for all the healthcare critics these days. But before you jump on the Down-with-Big-Pharma bandwagon it's worth taking a broader look at healthcare spending, and more importantly, value. A study by the Organisation for Economic Co-operation and Development found that the U.S spends 152 percent more on pharmaceuticals than the average OECD country. Disturbing statistic isn't it?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Google partners with pharmaceutical company for smart contact lens development
Yahoo News
A smart contact lens that can monitor the glucose levels in the eye is a step closer to reality, as Google has announced a partnership with Swiss pharmaceutical company Novartis to develop it. The technology giant first unveiled the concept in January, which works using tiny sensors and microchips fitted into contact lenses that can measure and read the amount of glucose in tears, before sending the information to a mobile device so diabetics can manage their condition.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Be a part of Innovation!

Banner Pharmacy Services will be recognized nationally as a clinical leader and trusted partner in providing innovative pharmacy services and coordinated patient care through convenient access and improved medication outcomes across the continuum.

Click here for Leadership opportunities

Contact: shaun.gustafson@bannerhealth.com
 


Cannabis, cognition and confusion in research
By Denise A. Valenti
Of the 22 states in the U.S. that allow for the medical use of marijuana, 13 specify Alzheimer's disease as one of the approved conditions. Some studies report benefits to AD patients, but other research is inconclusive. A suggested reason for its use is that marijuana may prove to be more effective than current treatments in breaking up the amyloid deposits that are characteristic of AD. The use of marijuana may prove to be an important aspect of treatment and prevention of neurodegenerative diseases such as Alzheimer's disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Pill look different? Shape and color changes may prompt lapses
The Los Angeles Times
In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals — coupled with insurance companies' efforts to keep healthcare costs low — often means that when they refill a prescription, patients get a familiar medication in a new shape or color. That may be a bad idea, a new study says.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Psychiatric provider status for pharmacist helps community treatment effort
American Society of Health-System Pharmacists
The Missouri Department of Mental Health's decision to approve a pharmacist for the role of psychiatric care provider has enabled an assertive community treatment team to serve clients more efficiently, according to the team leader. "There's no way we could get our clients the kind of close psychiatric attention, medical attention, that they would need without her — no way," said Nicole Morani, leader of the Places for People–IMPACT Team in St. Louis.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
New medication shows promise in treating common skin disease
Science Daily
An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis, according to a study published July 9 in the New England Journal of Medicine. The findings could eventually bring significant relief for many who suffer intense itching and other troubling features of atopic dermatitis, according to the study's lead author Dr. Lisa A. Beck, professor of Dermatology and Medicine at the University of Rochester Medical Center.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


Forget spoons: Measure in milliliters to avoid child drug-dosing errors
Daily Digest News
Using a milliliter-only unit of measurement can help to reduce confusion and medication errors when measuring doses for children, a new study suggests. The study, published in the August 2014 Pediatrics, "Unit of Measurement Used and Parent Medication Dosing Errors," notes that medication errors are common.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ADHD drugs not tested for safety, efficacy over time
Medscape
Studies supporting the approval of the majority of drugs used to treat attention-deficit/hyperactivity disorder in children were not designed to demonstrate long-term safety and efficacy of the drugs or detect rare adverse events, new research shows. Investigators at Boston Children's Hospital in Massachusetts found that the majority of studies carried out by sponsors prior to market approval of their ADHD drug were either too small, too short or both to extrapolate meaningful clinical gains during longer-term follow-up of children receiving drugs for ADHD.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Flu drug fighting resistant strains to seek US approval
Bloomberg
The first new type of flu drug in more than a decade could seek U.S. regulatory approval as early as next year, aided by U.S. government efforts to combat pandemics and biological threats. Japan's Fujifilm Holdings Corp. and partner MediVector Inc. have enrolled more than half the 1,600 patients needed for advanced U.S. studies on the medicine called favipiravir, Kouichi Yamada, senior operations manager of Fujifilm's pharmaceutical products division said in an interview.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Is clinical pharmacy really the future of our profession? (By Greg L. Alston)
Addictions leading to more dangerous situations for pharmacists (WISN-TV)
The frustrating lack of comparative effectiveness — Part I (By Mike Wokasch)
National, local Kentucky pharmacies work to prevent illegal use of medicines they sell (WYMT-TV via WKYT-TV)
New medication shows promise in treating common skin disease (ScienceDaily)

Don't be left behind. Click here to see what else you missed.


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Assistant Executive Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
July 16, 2014
July 9, 2014
July 2, 2014
June 25, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063